Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
about
Networks of fibers and factors: regulation of capsule formation in Cryptococcus neoformansCryptococcus and Phagocytes: Complex Interactions that Influence Disease OutcomeHost immunity to Cryptococcus neoformansCurrent trends in the prevalence of Cryptococcus gattii in the United States and CanadaThe CD4+ T-lymphocyte count is an important predictor for the prognosis of cryptococcosis.Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.Model-driven mapping of transcriptional networks reveals the circuitry and dynamics of virulence regulation.Is Development of a Vaccine against Cryptococcus neoformans Feasible?Sequencer-Based Capillary Gel Electrophoresis (SCGE) Targeting the rDNA Internal Transcribed Spacer (ITS) Regions for Accurate Identification of Clinically Important Yeast Species.Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.Generation of stable mutants and targeted gene deletion strains in Cryptococcus neoformans through electroporationMorphology and its underlying genetic regulation impact the interaction between Cryptococcus neoformans and its hostsGeographic distribution of patients affected by Cryptococcus neoformans/Cryptococcus gattii species complexes meningitis, pigeon and tree populations in Southern Brazil.Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection.Cryptococcus gattii molecular type VGII infection associated with lung disease in a goatPhylogenomic analyses reveal the diversity of laccase-coding genes in Fonsecaea genomesThe Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans.Molecular characterization of Cryptococcus neoformans isolated from the environment in Beijing, China.Disseminated cryptococcosis with recurrent multiple abscesses in an immunocompetent patient: a case report and literature review.Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant population.Computational Analysis Reveals a Key Regulator of Cryptococcal Virulence and Determinant of Host ResponseInfective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.Analysis of sphingolipids, sterols and phospholipids in human pathogenic Cryptococcus strains.What makes Cryptococcus gattii a pathogen?Alterations of zinc homeostasis in response to Cryptococcus neoformans in a murine macrophage cell line.Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil.High-Throughput Screen in Cryptococcus neoformans Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway Signaling.In Vitro Antifungal Susceptibility of Environmental Isolates of Cryptococcus spp. from the West Region of Cameroon.Rim Pathway-Mediated Alterations in the Fungal Cell Wall Influence Immune Recognition and Inflammation.Cryptococcosis in Atlántico, Colombia: an approximation of the prevalence of this mycosis and the distribution of the etiological agent in the environment.Long-term no-till: A major driver of fungal communities in dryland wheat cropping systems.Glucosamine stimulates pheromone-independent dimorphic transition in Cryptococcus neoformans by promoting Crz1 nuclear translocation.Fatal Cryptococcus gattii genotype VGI infection in an HIV-positive patient in Barranquilla, ColombiaHistone deacetylases: Targets for antifungal drug development.A review of Odongo-Aginya stain: the other alternative to India ink.Nutritional Requirements and Their Importance for Virulence of Pathogenic Cryptococcus Species.Innate immune evasion strategies against Cryptococcal meningitis caused by Cryptococcus neoformans.Exploring Virulence Determinants of Filamentous Fungal Pathogens through Interactions with Soil Amoebae.Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes.Had1 Is Required for Cell Wall Integrity and Fungal Virulence in Cryptococcus neoformans.
P2860
Q26741771-F7A07FC2-F5E3-426D-A25E-5F5565A21921Q26767978-A9E56B61-4C64-491F-B6E6-D7E38046B604Q26823438-643979AF-284C-4489-8378-2431427ACACAQ28080670-50D364F6-A5F7-4C11-8980-7AFABEC48FDAQ33575765-B97122BC-71C0-403D-9B75-AFF81F4DED3BQ34955594-9E206A47-A0F6-4730-B395-C4E4E3FA0DA1Q35561962-3F32F5E6-50FF-4EC8-8F02-CEB33E32D5C1Q35667534-FB12CB9F-D963-493D-BBED-65B1FDC6033BQ35997054-77BF6AD4-DEAA-46C5-B7D4-2DE6EF2A63B1Q36020365-DA245B8D-3DD8-4D17-9713-C0B5C35B7246Q36072583-3C4523A8-023D-43FC-B26B-8739DECECF92Q36078815-B5F1D63D-AADE-4399-8EEB-BAE5859C2683Q36113551-58F33E98-8D3A-41A2-A6AE-6E2979A50DF4Q36255360-70A7345D-9E92-4E35-96F9-CE0A63AAC6A0Q36273382-D8D4A834-8FBD-4191-868C-A7828BD129A6Q36276953-D7A34AFE-020D-4F7A-8EED-914AF008D498Q36344094-30B6688F-ECA0-4959-8B7D-73549159CA61Q36353667-E8148247-3614-4789-AE39-8D5161940E77Q36385226-79E9CB8F-3EBE-4246-9013-70DE3912E8CBQ36583160-E4D03937-402F-4530-8E7E-3347A05E438FQ36849909-7EF2ACED-4268-498F-A263-4C960F6DD2BAQ38546094-C2DD1EB4-6A67-47CF-85E2-791798DD56B8Q38623199-4569BD3B-1562-4284-B2DD-FDE182082E10Q38650835-BD89F5AF-71F5-4899-AEBF-7889DE9E709EQ38685355-8E4D74C9-77C2-4FB0-8F87-97821D1FBB8CQ39064815-5D487AAD-1C37-40EB-9F21-0079B91C202CQ40065529-8535A608-D8D6-4FF4-B475-DE8F1C2A2EB1Q40224360-50FC8787-778E-4C0B-AE84-977C1C6D46FCQ40351228-8EFAA698-5E6A-436D-B213-3AFE0FCA114DQ40930491-EED54F01-9AD6-4859-9699-636F0B190288Q41227219-46923E7A-E188-4F6E-B346-DA557DA7456BQ41229705-55A2CC4A-B0D5-4F94-9E32-379E32116F53Q42342353-EEA18491-DCF6-4312-A706-1DBA75C79896Q43077777-AE912AAB-7E01-4388-A2C1-9243197A7ED4Q46196122-60AF2111-E9FC-49E0-A07B-6909DDC0F53DQ46295778-BF317A45-1C73-4C72-8CC3-C5E7741AC446Q47095603-5EA5BDAB-B430-4D84-85BF-63CB9C354315Q47118449-ADEA2721-A725-42B6-BB60-6CFA3322FB90Q47118458-25CD7970-28D3-4D4E-8E1A-EDD23E43ECC6Q47300999-8296BA2B-330E-4933-99FA-496D28FCFDB1
P2860
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
@ast
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
@en
type
label
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
@ast
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
@en
prefLabel
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
@ast
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
@en
P2093
P2860
P50
P1476
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
@en
P2093
Kyung J Kwon-Chung
Tamara L Doering
P2860
P304
P356
10.1101/CSHPERSPECT.A019760
P577
2014-07-01T00:00:00Z